Valuation: Kenvue Inc.

Market Cap 3.69TCr 3.24TCr 3TCr 2.76TCr 5.22TCr 3,53400Cr 5.32TCr 36TCr 14TCr 1,73500Cr 14TCr 14TCr 5,99300Cr P/E 2026 *
20.2x
P/E 2027 * 18x
Enterprise Value 4.43TCr 3.89TCr 3.6TCr 3.31TCr 6.27TCr 4,24300Cr 6.39TCr 43TCr 17TCr 2,08400Cr 17TCr 16TCr 7,19500Cr EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.73x
Free-Float
98.9%
Yield 2026 *
4.41%
Yield 2027 * 4.51%
1 day-1.28%
1 week-1.69%
Current month+0.63%
1 month+6.01%
3 months+11.41%
6 months+13.05%
Current year+11.48%
1 week 19.04
Extreme 19.04
19.86
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap.
29/06
Starboard Value LP
OtherCompany 1,413 0.0001%
29/06Free

Director

1,413 0.0001%
10/06Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-1.69%-9.89%-24.29% 3.69TCr
+0.90%-0.63%-5.53%-0.39% 35TCr
-0.57%-2.90%-10.90%+1.37% 13TCr
+1.05%-0.19%+4.05%+22.87% 7.46TCr
-0.49%-4.01%-15.75%-20.80% 5.23TCr
-1.83%-4.42%-10.90%-58.01% 2.94TCr
-1.62%-0.92%-28.92%-33.78% 1.97TCr
-0.36%-1.38%+5.58%-0.93% 1.96TCr
+1.74%-0.67%+0.69%+23.50% 1.8TCr
-0.66%-3.24%-16.19%-0.13% 1.14TCr
Average -0.57%-0.98%-8.77%-9.06% 7.4TCr
Weighted average by Cap. -0.35%-0.67%-7.02%-2.97%

Financials

2026 *2027 *
Net sales 1.56TCr 1.37TCr 1.27TCr 1.17TCr 2.21TCr 1,49600Cr 2.25TCr 15TCr 5.94TCr 73TCr 5.87TCr 5.74TCr 2,53700Cr 1.6TCr 1.41TCr 1.3TCr 1.2TCr 2.27TCr 1,53400Cr 2.31TCr 16TCr 6.09TCr 75TCr 6.02TCr 5.89TCr 2,60200Cr
Net income 184.29Cr 161.64Cr 149.71Cr 137.75Cr 260.55Cr 18TCr 265.62Cr 1.78TCr 699.82Cr 8.66TCr 692.03Cr 676.9Cr 30TCr 206.48Cr 181.1Cr 167.73Cr 154.33Cr 291.91Cr 20TCr 297.59Cr 2TCr 784.07Cr 9.7TCr 775.34Cr 758.39Cr 34TCr
Net Debt 740.63Cr 649.61Cr 601.66Cr 553.59Cr 1.05TCr 71TCr 1.07TCr 7.17TCr 2.81TCr 35TCr 2.78TCr 2.72TCr 1,20200Cr 681.1Cr 597.39Cr 553.3Cr 509.09Cr 962.93Cr 65TCr 981.66Cr 6.59TCr 2.59TCr 32TCr 2.56TCr 2.5TCr 1,10600Cr
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
13/26/13 $19.23 -1.28% 3,98,73,974
10/26/10 $19.48 +1.56% 94,51,591
09/26/09 $19.18 -0.57% 1,44,46,508
08/26/08 $19.29 -2.48% 1,27,56,324
07/26/07 $19.78 +1.12% 1,63,17,432
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.23USD
Average target price
19.58USD
Spread / Average Target
+1.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock